WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...

In the first six months of 2025, 385 employees resigned from the Center for Drug Evaluation and Research, compared with under 130 staff during the same period last year.

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

The Department of Health and Human Services finalized the layoffs of thousands of employees after a Supreme Court ruling cleared the way for the Trump administration to proceed with mass firings ...

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Policy FDA layoffs could compromise safety of medications made at foreign factories, inspectors say Beyond staff cuts, the departures of some longtime investigators in recent months have left less ...